EU Calls For Suspension Of J&J's Ionsys
In a blow to Johnson & Johnson, the European Union's drug-regulating body has recommended suspending approval for the sale of Ionsys in Europe because of a defect with the pain medicine's...To view the full article, register now.
Already a subscriber? Click here to view full article